# A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)

> **NCT00770159** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 78 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** odanacatib
- **DRUG:** Comparator: placebo to MK0822

## Key facts

- **NCT ID:** NCT00770159
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2005-06
- **Final completion:** 2005-11
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2016-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770159, "A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00770159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*